Author
Listed:
- Francesco Millozzi
(Università Cattolica del Sacro Cuore
Sapienza University of Rome)
- Paula Milán-Rois
(IMDEA Nanociencia)
- Arghya Sett
(Inserm U1212
Luxembourg Institute of Science and Technology (LIST))
- Giovanni Delli Carpini
(Università Cattolica del Sacro Cuore)
- Marco De Bardi
(Fondazione Santa Lucia IRCCS)
- Miguel Gisbert-Garzarán
(IMDEA Nanociencia)
- Martina Sandonà
(Università Cattolica del Sacro Cuore
Fondazione Santa Lucia IRCCS)
- Ciro Rodríguez-Díaz
(IMDEA Nanociencia)
- Mario Martínez-Mingo
(IMDEA Nanociencia)
- Irene Pardo
(IMDEA Nanociencia)
- Federica Esposito
(Sapienza University of Rome
Fondazione Santa Lucia IRCCS)
- Maria Teresa Viscomi
(Università Cattolica del Sacro Cuore
Universitario Agostino Gemelli IRCCS)
- Marina Bouché
(Sapienza University of Rome)
- Ornella Parolini
(Università Cattolica del Sacro Cuore
Universitario Agostino Gemelli IRCCS)
- Valentina Saccone
(Università Cattolica del Sacro Cuore
Universitario Agostino Gemelli IRCCS)
- Jean-Jacques Toulmé
(Inserm U1212
Novaptech)
- Álvaro Somoza
(IMDEA Nanociencia
Centro Nacional de Biotecnología (CNB-CSIC))
- Daniela Palacios
(Università Cattolica del Sacro Cuore
National Research Council (CNR))
Abstract
Inefficient targeting of muscle stem cells (MuSCs), also called satellite cells, represents a major bottleneck of current therapeutic strategies for muscular dystrophies, as it precludes the possibility of promoting compensatory regeneration. Here we describe a muscle-targeting delivery platform, based on gold nanoparticles, that enables the release of therapeutic oligonucleotides into MuSCs. We demonstrate that AuNPs conjugation to an aptamer against α7/β1 integrin dimers directs either local or systemic delivery of microRNA-206 to MuSCs, thereby promoting muscle regeneration and improving muscle functionality, in a mouse model of Duchenne Muscular Dystrophy. We show here that this platform is biocompatible, non-toxic, and non-immunogenic, and it can be easily adapted for the release of a wide range of therapeutic oligonucleotides into diseased muscles.
Suggested Citation
Francesco Millozzi & Paula Milán-Rois & Arghya Sett & Giovanni Delli Carpini & Marco De Bardi & Miguel Gisbert-Garzarán & Martina Sandonà & Ciro Rodríguez-Díaz & Mario Martínez-Mingo & Irene Pardo & F, 2025.
"Aptamer-conjugated gold nanoparticles enable oligonucleotide delivery into muscle stem cells to promote regeneration of dystrophic muscles,"
Nature Communications, Nature, vol. 16(1), pages 1-19, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-024-55223-9
DOI: 10.1038/s41467-024-55223-9
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-024-55223-9. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.